« All Events

11th Annual Access to Innovation

February 25 @ 8:00 am - 6:30 pm
Detailed Event Agenda

Join us on February 25, 2026, for our annual Access to Innovation Conference, a full-day event showcasing how cutting-edge research in British Columbia is translated into real-world health and economic impact. Centered on the theme “Discovery to Impact: Life Sciences in Action,” the event explores the journey from early discovery through development, commercialization, and adoption, with a particular emphasis on the transformative role of AI across the sector.​ 

The conference convenes leaders from industry, research, and government to discuss trends, innovation pathways, and policy frameworks that enable the growth of life sciences. Connect with decision-makers, share insights, and deepen your understanding of the most relevant topics in life sciences and AI. 

 

Event Details:

Date: Wednesday, February 25, 2026

Location: Vancouver Convention Centre West – Summit Level 3

F&B Offerings: Buffet lunch, coffee, tea, water, and light reception refreshments will be provided.

Suggested Attire: Business

 

Firesides

Join us for intimate conversations with leading voices shaping the future of life sciences and healthcare innovation:

  • Wendy Hurlburt, President & CEO, Life Sciences BC, and Dr. Allen Eaves, Founder & CEO, STEMCELL Technologies
  • Sarah Roth, CEO, BC Cancer Foundation, and Erin Keith, VP of Oncology, Novartis – discussing the partnership between research, philanthropy, and industry in advancing cancer care
  • Tamer Mohamed, Founder & CEO, Aspect Biosystems, and Justin Young, Partner, Emerging and High Growth Companies, Osler, Hoskin & Harcourt LLP sharing the story of Aspect’s inspiring growth.

Panels

Join us for timely conversations impacting the life sciences sector

Canada’s Genomic Future: Ethics and Data Sovereignty presented by Genome British Columbia

Cross-Border Price Pressures: What U.S. Most Favoured Nation Means for Canada presented by AstraZeneca

From Discovery to Patient: Breaking Barriers in Clinical Research presented by GSK

AI -powered Clinical Trials – Are We Ready to Leverage Electronic Health Data? presented by Clinical Trials British Columbia

Public Trust in Science: Challenges, Experiences, and Pathways Forward

Keynote Speakers

Company Presentations

The IP Journey: Stories of Portfolio Building and Business Growth Presented by Oyen Wiggs

Discover how innovative life sciences companies leverage intellectual property to drive business growth. Hear directly from leadership at:

  • IKOMED Technologies Inc
  • SeraGene Therapeutics
  • Sonic Incytes
  • Vesalius Cardiovascular Inc.
  • HealthTech Connex Inc. 

Each presenter shares their IP journey—from early patent strategy to building portfolios that attract investment and fuel expansion. Learn how these companies navigate intellectual property protection while scaling from concept to commercialization, and gain practical insights into IP’s strategic role in building successful life sciences ventures.

Additional Speakers

Stay tuned as we release more details!

Tickets:

  • LSBC Members: $349
  • LSBC Non-Members: $499
  • Students: $199

For more information, please contact:

Alysia Golka

Manager, Events

agolka@lifesciencesbc.ca

SUBSCRIBE TO OUR NEWSLETTERS!

Details

  • Date: February 25
  • Time:
    8:00 am - 6:30 pm
  • Event Category:

Organizer

Venue

Related Events